These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 5052388)
41. Current and developing strategies for monitoring and reversing direct oral anticoagulants in patients with non-valvular atrial fibrillation. Sarma A; Giugliano RP Hosp Pract (1995); 2015; 43(5):258-67. PubMed ID: 26559852 [TBL] [Abstract][Full Text] [Related]
42. [Source of error in the supervision of postoperative anticoagulant therapy]. Senst W; Nowak W; Wolf E Zentralbl Chir; 1967; 92(26a Pt 1):1432-4. PubMed ID: 5595671 [No Abstract] [Full Text] [Related]
43. Anticoagulant treatment of thromboembolism with intravenous heparin therapy in the early postoperative period following total joint arthroplasty. Della Valle CJ; Jazrawi LM; Idjadi J; Hiebert RN; Stuchin SA; Steiger DJ; Di Cesare PE J Bone Joint Surg Am; 2000 Feb; 82(2):207-12. PubMed ID: 10682729 [TBL] [Abstract][Full Text] [Related]
44. [Remarks on the use of Ca heparinate by subcutaneous route in anticoagulant therapy]. Vivien P Phlebologie; 1973; 26(1):15-21. PubMed ID: 4724445 [No Abstract] [Full Text] [Related]
45. [Studies on the anticoagulant effect of heparin "in vivo" (author's transl)]. Lucia JF; Ercoreca L; García Zueco JC; Cinto F; Raichs A Sangre (Barc); 1976; 21(1):77-86. PubMed ID: 772843 [No Abstract] [Full Text] [Related]
46. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo. Li DW; Lee IS; Sim JS; Toida T; Linhardt RJ; Kim YS Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567 [TBL] [Abstract][Full Text] [Related]
47. New perspectives for treatment of pulmonary embolism. Simonneau G Haemostasis; 1998; 28 Suppl 3():95-9. PubMed ID: 10069768 [TBL] [Abstract][Full Text] [Related]
48. Letter: Decreased sensitivity to oral anticoagulant therapy after attacks of migraine. Narasimhan P Lancet; 1974 Nov; 2(7889):1143. PubMed ID: 4139440 [No Abstract] [Full Text] [Related]
49. Anticoagulant potency of mucosal and lung heparin. McMahon FG; Jain AK; Ryan JR; Lefton TE Clin Pharmacol Ther; 1975 Jan; 17(1):79-82. PubMed ID: 1168110 [TBL] [Abstract][Full Text] [Related]
50. Secondary prophylaxis of venous thromboembolism: rational use of oral anticoagulants. Piovella F; Siragusa S; Barone M; Beltrametti C; Carbone S; Vicentini L; Ascari E Haematologica; 1995; 80(2 Suppl):87-91. PubMed ID: 7543072 [No Abstract] [Full Text] [Related]
51. Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins? Baglin T J Thromb Haemost; 2012 Aug; 10(8):1702-3. PubMed ID: 22672412 [No Abstract] [Full Text] [Related]
52. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin]. Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273 [TBL] [Abstract][Full Text] [Related]
53. The heparin management test: a new device for monitoring anticoagulation during coronary intervention. Helft G; Bartolomeo P; Zaman AG; Worthley SG; Chokron S; Le Pailleur C; Beygui F; Le Feuvre C; Metzger JP; Vacheron A; Samama MM Thromb Res; 1999 Dec; 96(6):481-5. PubMed ID: 10632472 [TBL] [Abstract][Full Text] [Related]
59. [Problems posed by the control of oral anticoagulant therapy]. Capel P Rev Med Brux; 1983 Jan; 4(1):23-6. PubMed ID: 6836203 [No Abstract] [Full Text] [Related]
60. ANTICOAGULANT THERAPY; APPRAISAL OF ITS LABORATORY CONTROL. WARE AG; STERLING RE; STRAGNELL R Angiology; 1964 Jan; 15():11-6. PubMed ID: 14104834 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]